| Wei Bing Lu |
Founder of Xi'an Tianxing Bio-Pharmaceutical Co., Ltd. and Xian Xingji Electronic Engineering Co., Wei Bing Lu presently holds the position of Chairman & Chief Executive Officer of Skystar Bio-Pharmaceutical Co. and Chairman & President for Xi'an Tianxing Bio-Pharmaceutical Co., Ltd.
In the past Mr. Lu occupied the position of Chairman & President for Xian Xingji Electronic Engineering Co. and Chief Executive Officer of Cyber Group Network Corp.
He received an undergraduate degree from Wuhan University and an MBA from Xi'an Jiaotong University. |
| Wei Rong Shen |
Currently, Wei Rong Shen is Chairman at Shaanxi Boao Pharmaceutical Co. Ltd. Mr. Shen is also on the board of Skystar Bio-Pharmaceutical Co., Biochemistry & Molecular Biology Institute, Shaanxi Food Technology Institute and Society For Microbiology Research Federation and Deputy Director at Shaanxi Province Institute of Microbiology.
He received an undergraduate degree from Northwest University (China). |
| Mark D. Chen |
Mark D. Chen founded Suredata, Inc. Mr. Chen is on the board of Global Cord Blood Corp. and Skystar Bio-Pharmaceutical Co. and Managing Partner at Pantheon Pacific Capital Management Ltd.
In the past he was Senior Executive Officer at Suredata, Inc., Managing Director at Easton Capital Investment Group and Chairman, President & Chief Executive Officer of Pantheon China Acquisition Corp.
He received a graduate degree from The Pennsylvania State University, an undergraduate degree from Shanghai Jiao Tong University and an MBA from Columbia Business School. |
| Cheng Tun Qu |
Cheng Tun Qu is on the board of Skystar Bio-Pharmaceutical Co., Shaanxi Province Chemical Engineering Association and Shaanxi Province Environmental Protection Association and Head-Environmental Engineering Department at Xi'an Shiyou University.
He received a graduate degree from Southwest Petroleum University, a doctorate from Xi'an Jiaotong University and an undergraduate degree from Northwest University (China). |
